Objectively measured physical activity and inflammatory markers among US adults with diabetes: Implications for attenuating disease progression

Mayo Clinic Proceedings

Volumn 88, Issue 9, 2013, Pages 942-951

  Loprinzi, Paul D ^a   Ramulu, Pradeep L ^b  

^a BELLARMINE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ACCELEROMETER; ADULT; AGED; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; UNITED STATES;

EID: 84884623696     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.05.015     Document Type: Article

References (55)

1. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease: insights from the Framingham Study. JAMA. 1992;267(9): 1253-1256.
2. Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J. 1993;125(3): 855-863.
3. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol. 2001;54(3): 316-322.
4. Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA. 1985;254(14): 1932-1937.
5. Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM. 2003; 96(11): 793-807.
6. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol. 2009;27(13): 2217-2224.
7. Prins RC, Rademacher BL, Mongoue-Tchokote S, et al. C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results. Urol Oncol. 2012;30(1): 33-37.
8. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917): 860-867.
9. Mantovani A, Pierotti MA. Cancer and inflammation: a complex relationship. Cancer Lett. 2008;267(2): 180-181.
10. Erlinger TP, Muntner P, Helzlsouer KJ. WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiol Biomarkers Prev. 2004;13(6): 1052-1056.
11. Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48(4): 155-170.
12. Twig G, Afek A, Shamiss A, et al. White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care. 2013; 36(2): 276-282.
13. Hatanaka E, Monteagudo PT, Marrocos MS, Campa A. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol. 2006; 146(3): 443-447.
14. Gkrania-Klotsas E, Ye Z, Cooper AJ, et al. Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies. PLoS One. 2010;5(10):e13405.
15. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51(2): 455-461.
16. Mugabo Y, Li L, Renier G. The connection between C-reactive protein (CRP) and diabetic vasculopathy: focus on preclinical findings. Curr Diabetes Rev. 2010;6(1): 27-34.
17. Mahajan A, Tabassum R, Chavali S, et al. High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. J Clin Endocrinol Metab. 2009;94(6): 2123-2127.
18. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52(1): 102-110.
19. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, PerrenA, Ehses JA. Islet inflammation in type 2 diabetes: frommetabolic stress to therapy. Diabetes Care. 2008;31(suppl 2):S161-S164.
20. Hull RL, Westermark GT, Westermark P, Kahn SE. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab. 2004;89(8): 3629-3643.
21. Fonseca VA. Defining and characterizing the progression of type 2 diabetes. Diabetes Care. 2009;32(suppl 2):S151-S156.
22. Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008;30(2): 65-84.
23. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13): 1227-1239.
24. Soinio M, Marniemi J, Laakso M, Lehto S, Ronnemaa T. Highsensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care. 2006;29(2): 329-333.
25. Bruno G, Fornengo P, Novelli G, et al. C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study. Diabetes. 2009;58(4): 926-933.
26. Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010;33(2): 442-449.
27. Loprinzi P, Cardinal B, Crespo C, et al. Objectively measured physical activity and C-reactive protein: National Health and Nutrition Examination Survey 2003-2004. Scand J Med Sci Sports. 2013;23(2): 164-170.
28. Ploeger HE, Takken T, de Greef MH, Timmons BW. The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review. Exerc Immunol Rev. 2009;15: 6-41.
29. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/ nhanes.htm. Accessed March 13, 2013.
30. Summary of revisions for the 2010 Clinical Practice Recommendations. Diabetes Care. 2010;33(suppl 1):S3.
31. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
32. National Health and Nutrition Examination Survey: Laboratory Procedures Manual. http://wwwn.cdc.gov/nchs/nhanes/search/ datapage.aspx?fComponent= dLaboratory&CycleBeginYear=2005. Accessed March 13, 2013.
33. Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008;40(1): 181-188.
34. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5): 373-383.
35. Herrmann SD, Barreira TV, Kang M, Ainsworth BE. How many hours are enough? Accelerometer wear time may provide bias in daily activity estimates. J Physical Activity Health. In press.
36. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey, 2010. Overviewof NHANES Survey Design and Weights. http://www.cdc.gov/nchs/tutorials/ environmental/orientation/sample-design/. Accessed March 13, 2013.
37. National Health and Nutrition Examination Survey: Specifying Weighting Parameters. http://www.cdc.gov/nchs/tutorials/ NHANES/SurveyDesign/Weighting/ OverviewKey.htm#base- weight. Accessed March 13, 2013.
38. National Health and Nutrition Examination Survey. Using Stata to account for complex survey design. http://www.cdc.gov/ nchs/tutorials/nhanes/stata-tips. htm. Accessed March 13, 2013.
39. Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care. 2004;27(1): 216-222.
40. Dekker MJ, Lee S, Hudson R, et al. An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus. Metabolism. 2007;56(3): 332-338.
41. Johannsen NM, Swift DL, Johnson WD, et al. Effect of different doses of aerobic exercise on total white blood cell (WBC) and WBC subfraction number in postmenopausal women: results from DREW. PLoS One. 2012;7(2):e31319.
42. Jae SY, Heffernan KS, Lee MK, Fernhall B, Park WH. Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus. Am J Cardiol. 2008;102(6): 700-703.
43. Church TS, Finley CE, Earnest CP, Kampert JB, Gibbons LW, Blair SN. Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. Int J Obes Relat Metab Disord. 2002;26(6): 805-813.
44. Johannsen NM, Priest EL, Dixit VD, Earnest CP, Blair SN, Church TS. Association of white blood cell subfraction concentration with fitness and fatness. Br J Sports Med. 2010; 44(8): 588-593.
45. Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol. 2001;153(3): 242-250.
46. Donath MY, Ehses JA, Maedler K, et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes. 2005;54(suppl 2):S108-S113.
47. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121): 860-867.
48. Stefanov T, Temelkova-Kurktschiev T, Koehler C, Henkel E, Schaper F, Hanefeld M. Association of physical activity with insulin resistance, subclinical inflammation, coagulation, and fibrinolytic biomarkers among population at high risk for type 2 diabetes. Folia Med (Plovdiv). 2012;54(2): 32-39.
49. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3): 327-334.
50. Buttner P, Mosig S, Lechtermann A, Funke H, Mooren FC. Exercsise affects the gene expression profiles of human white blood cells. J Appl Physiol. 2007;102(1): 26-36.
51. Radom-Aizik S, Zaldivar F, Leu SY, Galassetti P, Cooper DM. Effects of 30 min of aerobic exercise on gene expression in human neutrophils. J Appl Physiol. 2008;104(1): 236-243.
52. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29(6): 1433-1438.
53. Ren JM, Semenkovich CF, Gulve EA, Gao J, Holloszy JO. Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. J Biol Chem. 1994;269(20): 14396-14401.
54. Colberg SR, Sigal RJ, Fernhall B, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010;33(12): 2692-2696.
55. Chen Z, Black MH, Watanabe RM, et al. Self-reported physical activity is associated with beta-cell function in Mexican American adults. Diabetes Care. 2013;36(3): 638-644.